Evidence map›Paper›PMID 17382392›Full record

ArticleMolecular immunology2007

Immunoglobulin kappa enhancers are differentially regulated at the level of chromatin structure.

Barbara S Nikolajczyk, Sylvia H Sardi, Joseph R Tumang, Lisa M Ganley-Leal

Open access · greenAbstract readComparative Study
In one paragraph

Article in Molecular immunology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Barbara S NikolajczykDepartments of Microbiology and Medicine, Boston University School of Medicine, Boston, MA 02118, USA. bnikol@bu.edu
Sylvia H Sardi
Joseph R Tumang
Lisa M Ganley-Leal
Boston University · USBoston Medical Center · USFeinstein Institute for Medical Research · US

Funding

REGULATION AND FUNCTION OF CYCLIN D3 IN B CELL SUBSETSP01AI060896 · NIAID · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI ROTHSTEIN, THOMAS L · 2004 to 2008
$4.5M
Mechanisms regulating immunoglobulin gene transcriptionR01AI054611 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI NIKOLAJCZYK, BARBARA · 2003 to 2007
$1.2M
NIAID NIH HHS AI60896NIAID NIH HHS P01 AI060896NIAID NIH HHS R01 AI054611NIAID NIH HHS R01 AI54611
6 · The paper itself

Abstract

The kappa intronic and the kappa 3' enhancers synergize to regulate recombination and transcription of the Ig kappa locus. Although these enhancers have overlapping functions, the kappa i enhancer appears to predominate during receptor editing, while the kappa 3' enhancer may be more important for initiating Ig kappa germline transcription to target locus recombination and, later in development, somatic hypermutation. Changes in chromatin structure appear to regulate both enhancers, and previous reports suggest that both enhancers are packaged into an accessible chromatin structure only in B lineage cells. Why these enhancers cannot activate the demethylated, accessible, protein-associated Ig kappa allele in pro-B cells is not known. Furthermore, how the enhancers function to reactivate the locus for receptor editing or to quantitatively promote hypermutation in B cells is vague. Quantitative analysis of Ig enhancer chromatin structure in murine pro-, pre-and splenic B cells demonstrated that the kappa i enhancer maintains a highly accessible chromatin structure under a variety of conditions. This stable chromatin structure mirrored the highly accessible structure characterizing the Ig mu intronic enhancer, despite the fact that Ig mu is activated prior to Ig kappa during B cell development. Surprisingly, parallel analysis of the kappa 3' enhancer demonstrated its accessible chromatin structure is markedly unstable, as characterized by sensitivity to changes in environmental conditions. These data unexpectedly suggest that kappa locus regulation is compartmentalized along the gene in B lineage cells. Furthermore, these findings raise the possibility that environmentally dependent regulation of kappa 3' enhancer structure underlies changes in kappa activation during B cell development.

Indexed as

Enhancer Elements, GeneticAnimalsB-Lymphocyte SubsetsCell DifferentiationCells, CulturedChromatinGene Expression RegulationImmunoglobulin kappa-ChainsImmunoglobulin mu-ChainsMiceMice, Inbred BALB CSpleenChromatinImmunoglobulin kappa-ChainsImmunoglobulin mu-Chains

Identifiers

PMID17382392
PMCPMC2442924
OpenAlexW2021946716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.